Related Experiment Video
Updated: Feb 21, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Combining proton FLASH and spatially fractionated radiotherapy: experimental and simulation-based dosimetric
Gulakhshan Mustafa Hamad1, Yannick Poirier1, Sina Mossahebi1
1Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, United States of America.
This study shows combining ultra-high dose rate (UHDR) proton therapy with spatially fractionated radiotherapy (SFRT) is feasible using a novel collimator design. A validated Monte Carlo simulation framework can optimize future UHDR-SFRT treatments.
Area of Science:
- Radiation Oncology
- Medical Physics
- Biomedical Engineering
Background:
- Ultra-high dose rate (UHDR) proton therapy and spatially fractionated radiotherapy (SFRT) are advanced techniques for improved tumor control and normal tissue sparing.
- Integrating UHDR proton therapy with SFRT may offer synergistic benefits, but practical implementation requires further research.
Purpose of the Study:
- To develop and validate a Monte Carlo (MC) simulation framework for designing multi-slot collimators to generate planar minibeams (PMBs) under UHDR conditions.
- To explore the integration of UHDR proton therapy with SFRT for enhanced tumor control and minimized normal tissue damage.
Main Methods:
- A tungsten alloy multi-slit collimator was designed to produce PMBs (508-micron width, 1524-micron center-to-center spacing).
- Dosimetric characterization was performed using a 250 MeV UHDR-capable proton beam, measuring dose distributions in solid water phantoms.
- TOPAS MC toolkit was used to model collimator configurations, validating measurements and evaluating designs for preclinical UHDR-SFRT studies.
Main Results:
- The prototype collimator successfully generated PMBs at 250 MeV with UHDR dose rates (peak 179.3 Gy/s, valley 82 Gy/s).
- Measured depth of convergence was 80 mm with a peak-to-valley dose ratio (PVDR) of 1.8.
- MC simulations closely matched experimental data (RMSPE < 4.50%), and alternative designs showed reduced PVDR with closer spacing.
Conclusions:
- The study confirms the feasibility of combining UHDR proton therapy and SFRT using a 250 MeV proton beam.
- The validated MC simulation framework provides a powerful tool for designing and optimizing collimators for UHDR-SFRT applications.
More Related Videos
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
10:48PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017